AIM: The aim of this study was to evaluate the dose-volume histogram parameters for late hematuria and rectal hemorrhage in patients receiving radiotherapy after radical prostatectomy. PATIENTS AND METHODS: Data of 86 patients treated between January 2006 and June 2019 were retrospectively evaluated. The median radiation dose was 64 Gy in 32 fractions. Receiver operating characteristic (ROC) curves were used to identify optimal cut-off values for late adverse events. RESULTS: Eleven patients experienced hematuria, and the 5-year cumulative rate was 18%. Four patients experienced rectal hemorrhage, and the 5-year cumulative rate was 7%. ROC curve analysis demonstrated the following significant cut-off values: bladder V50 Gy: 43% (p=0.02) and V40 Gy: 50% (p=0.03) for hematuria, and rectum V60 Gy: 13% (p=0.04) and V50 Gy: 33% (p=0.03) for rectal hemorrhage. CONCLUSION: This is the first study to identify dose constraints that may reduce hematuria and rectal hemorrhage in patients receiving radiotherapy in the postoperative setting. Copyright
AIM: The aim of this study was to evaluate the dose-volume histogram parameters for late hematuria and rectal hemorrhage in patients receiving radiotherapy after radical prostatectomy. PATIENTS AND METHODS: Data of 86 patients treated between January 2006 and June 2019 were retrospectively evaluated. The median radiation dose was 64 Gy in 32 fractions. Receiver operating characteristic (ROC) curves were used to identify optimal cut-off values for late adverse events. RESULTS: Eleven patients experienced hematuria, and the 5-year cumulative rate was 18%. Four patients experienced rectal hemorrhage, and the 5-year cumulative rate was 7%. ROC curve analysis demonstrated the following significant cut-off values: bladder V50 Gy: 43% (p=0.02) and V40 Gy: 50% (p=0.03) for hematuria, and rectum V60 Gy: 13% (p=0.04) and V50 Gy: 33% (p=0.03) for rectal hemorrhage. CONCLUSION: This is the first study to identify dose constraints that may reduce hematuria and rectal hemorrhage in patients receiving radiotherapy in the postoperative setting. Copyright
Authors: Michel Bolla; Hein van Poppel; Bertrand Tombal; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Marc Colombel; Cees van de Beek; Paul Verhagen; Alphonsus van den Bergh; Cora Sternberg; Thomas Gasser; Geertjan van Tienhoven; Pierre Scalliet; Karin Haustermans; Laurence Collette Journal: Lancet Date: 2012-10-19 Impact factor: 79.321
Authors: Thomas M Pisansky; Shree Agrawal; Daniel A Hamstra; Bridget F Koontz; Stanley L Liauw; Jason A Efstathiou; Jeff M Michalski; Felix Y Feng; Matthew C Abramowitz; Alan Pollack; Mitchell S Anscher; Drew Moghanaki; Robert B Den; Kevin L Stephans; Anthony L Zietman; W Robert Lee; Michael W Kattan; Andrew J Stephenson; Rahul D Tendulkar Journal: Int J Radiat Oncol Biol Phys Date: 2016-09-03 Impact factor: 7.038
Authors: Grant K Hunter; Kristin Brockway; Chandana A Reddy; Sana Rehman; Lawrence J Sheplan; Kevin L Stephans; Jay P Ciezki; Ping Xia; Rahul D Tendulkar Journal: Pract Radiat Oncol Date: 2012-09-19
Authors: Daniel J Tandberg; Taofik Oyekunle; W Robert Lee; Yuan Wu; Joseph K Salama; Bridget F Koontz Journal: Int J Radiat Oncol Biol Phys Date: 2018-02-08 Impact factor: 7.038
Authors: Sameer K Nath; Ajay P Sandhu; Brent S Rose; Daniel R Simpson; Polly D Nobiensky; Jia-Zhu Wang; Fred Millard; Christopher J Kane; J Kellogg Parsons; Arno J Mundt Journal: Int J Radiat Oncol Biol Phys Date: 2009-11-24 Impact factor: 7.038
Authors: Chad R Ritch; Chaochen You; Alexandra T May; S Duke Herrell; Peter E Clark; David F Penson; Sam S Chang; Michael S Cookson; Joseph A Smith; Daniel A Barocas Journal: Urology Date: 2014-04-18 Impact factor: 2.649
Authors: Adil S Akthar; Anthony C Wong; Akash D Parekh; Greg Hubert; Christina H Son; Charles A Pelizzari; Stanley L Liauw Journal: Adv Radiat Oncol Date: 2018-05-08